[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-SPRO":3,"homepage-market-summary":31,"stock-news-SPRO":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"SPRO","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Spero Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.","25","Cambridge, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},1.14,1.2,1.22,1.13,1.17,-0.03,-2.56,718835.204737,1439,1.1593,3.08,1.08,786645.5172964581,3,2244,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":154},"success",[34,41,48,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":54,"sparkline":55,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":14,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":54,"sparkline":76,"date":5},"VIX","CBOE VIX",15.41,0.33,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":14,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":54,"sparkline":91,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":14,"sparkline":98,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[100,105,110,115,120,125,130,134,139,144,149],{"name":101,"etf":102,"change":103,"price":104,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":106,"etf":107,"change":108,"price":109,"is_up":54},"Financials","XLF",0.89,54.23,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":116,"etf":117,"change":118,"price":119,"is_up":54},"Consumer Cycl","XLY",0.31,111.7,{"name":121,"etf":122,"change":123,"price":124,"is_up":54},"Consumer Staples","XLP",2.11,83.42,{"name":126,"etf":127,"change":128,"price":129,"is_up":54},"Energy","XLE",2.97,65.24,{"name":131,"etf":132,"change":74,"price":133,"is_up":54},"Industrials","XLI",168.4,{"name":135,"etf":136,"change":137,"price":138,"is_up":54},"Materials","XLB",0.59,49.27,{"name":140,"etf":141,"change":142,"price":143,"is_up":54},"Real Estate","XLRE",0.69,40.85,{"name":145,"etf":146,"change":147,"price":148,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":150,"etf":151,"change":152,"price":153,"is_up":54},"Comm Services","XLC",0.73,112.07,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":161,"name":162,"price":163,"change":164,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":166,"name":167,"price":168,"change":169,"is_up":54},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":171,"name":172,"price":173,"change":21,"is_up":14},"IWM","iShares Russell 2000",277.63,{"ticker":4,"count":175,"articles":176},6,[177,183,189,195,201,206],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"New Spero hires get stock awards, but vesting starts after a year - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQT1kzQjVXdzZDQUtBSHgyV1MwYnd1Ui1BQjVrMk50T19hTEZkazMwNm1fOW5VaDdJOG5jWkxROGdKQmdNOHp6cmxkdjVwd2lTQ1JjeGt4dlhCNWl1c0ZjWFhLODhraFpTNFVWdUduVUw3Q0UtU1BzLU5aeEtkTFRxVDZ0ek5RTmhMdWRTZmhDMUpub1p0LTM3WENKNUFyVC1QdTY0ZW5qa1AzaVVnTEJKZC1rd1ZJcTlqR1ZzSjRYZw?oc=5","Fri, 02 Oct 2026 20:05:00 GMT","New Spero hires get stock awards, but vesting starts after a year Stock Titan","Stock Titan",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"Spero Therapeutics grants 556,000 awards and gets USD 6.00 target for Spero Therapeutics stock - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6AFBVV95cUxQa0xsb3NkWUZWVnpOSEhhU1NsbXZubnAzSFdtRkhHeWFqQ3lobWs0aVdNaG9xOFJfdXNPYzFHX25oY0RXZ3BKVm9SLWlMemxHTEVjWDI0WUxta3JXMUp6bUp0Q3ZZVkt5U2NIQ0xYQWlpekJVemloZzgta3JuelpYT0cxMWN3N3VNaDlWcDNhcVpKb09FZzJqM1ZoWnZrSDdldHZmSVl0M0pkMl9rSmtUM1pLdEc4clVPcWJTZGtWMlJkUXd6MDVWTXJNVTk4VUVfVnZsTERwcUV4c2U2cmpIY2tNYjFicEJE?oc=5","Tue, 06 Oct 2026 22:28:46 GMT","Spero Therapeutics grants 556,000 awards and gets USD 6.00 target for Spero Therapeutics stock AD HOC NEWS","AD HOC NEWS",{"title":190,"link":191,"pubDate":192,"description":193,"source":194},"Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 02 Oct 2026 20:10:06 GMT","Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The Manila Times","The Manila Times",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"SPRO Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slip - Quarterly Earnings Report - https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxQd1VwRHczbkdCOU9IX0dHc0xOX3lIVkJpTDU1TmJFQlZlWkl3UXF0NVVVRmNEUThudHkxcWdrZ3JhRUwwSWpiS3dwNlY0aUpvWGxBQVRENWIzTm1zOTRyR3hnel90WVNTSDBobmdXanZBUjhKVlYzUzJDMEJIWFVOOXVNNUY5X2ZLSjhQTHlrRHRFNTFYcTlQMGY5SVQ2cjFvNVJXaG9FRUMzVXM?oc=5","Tue, 06 Oct 2026 11:32:32 GMT","SPRO Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slip - Quarterly Earnings Report https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fwww.dars.gov.et\u002F",{"title":202,"link":203,"pubDate":204,"description":205,"source":188},"Spero Therapeutics targets SP001 trial for 2027: Spero Therapeutics stock gains 3.85 percent - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5AFBVV95cUxPWXI1aWNMUTd0TjE4MzdjUXVFUmR6MGdReEtUbi1ES3dZNUhnMWJ3Mkxka2VTdENGTjdaRFlydVNfWVZ6V3VLdVBCSGozS2ZmTHdjcWpQM0tNSmVDX0VwdE1mOUpOWEg5SWZFdjNJLXlGVGZHRHNkZi1RSWJJR0lldVJzU2x6dlVQMUFHVDNxQ2g4SGM1M2tZN2REekh0U0xaQm9OT1BvbG1sbUJLYV83ZVQyTjRjUVU5Z3FVcDZQb0RoVmRNRnplRHo1R0M2R1ZVT21QQkt5VGdQRUhManU5NDRtMEg?oc=5","Thu, 08 Oct 2026 13:35:17 GMT","Spero Therapeutics targets SP001 trial for 2027: Spero Therapeutics stock gains 3.85 percent AD HOC NEWS",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Russian plague outbreak could boost these under-the-radar pharma stocks - Invezz","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxOMG9zWnZvcGJmX05ldGltY1A1ZUpsSTM0cldqZFpObGhjYmRRMkV0TlU4WURxRldKaXFQMU0taW5xcjY3Qks4RTJQUHRXaldsZG0zUjk4TFV0S2RrVTZYOGpLR3o4UlpzdmdTYlhldUZzaG4zRnVjejViRE9oOXJzdXhPdW5Yakp2Z0UwNHFUeS1hdm9YUUNwQ3hoN0RBVlFnSENKbjgwVzFrdlE?oc=5","Mon, 05 Oct 2026 23:29:56 GMT","Russian plague outbreak could boost these under-the-radar pharma stocks Invezz","Invezz"]